RNXT Stock Analysis: Buy, Sell, or Hold?
RNXT - RenovoRx, Inc. Common Stock
$1.06
0.10 (10.61%)
▲
5d:
+9.83%
30d:
+15.2%
90d:
+20.0%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
7d
Get Alerted When RNXT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: RNXT is 9.3% above its trading range ($0.97). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: RNXT is 9.3% above its trading range ($0.97). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: RNXT is currently trading at $1.06, which is considered extended relative to its 30-day fair value range of $0.87 to $0.97.
Technical Outlook: Technically, RNXT is in a downtrend. Immediate support is located at $0.84, while resistance sits at $1.10. The stock is showing strong short-term momentum, up 10.6% recently.
Market Sentiment: RNXT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.03 (+563.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RNXT is in a downtrend. Immediate support is located at $0.84, while resistance sits at $1.10. The stock is showing strong short-term momentum, up 10.6% recently.
Market Sentiment: RNXT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.03 (+563.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.87 -
$0.97
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+9.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.6%)
- BULLISH: Trading 563.2% below Wall St target ($7.03)
- CAUTION: Extended 9.3% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$0.87 -
$0.97
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.84
Resistance Level
$1.10
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.07
Wall Street Target
$7.03
(+563.2%)
Revenue Growth (YoY)
185.8%
Share & Embed Analysis
Last updated: August 04, 2026 5:55 AM ET
Data refreshes hourly during market hours. Next update: 6:55 AM
Data refreshes hourly during market hours. Next update: 6:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNXT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
